Xuejiao Yang

The Neutrophil-to-Lymphocyte Ratio (NLR) Predicts the Prognosis of Unresectable Intermediate and Advanced Hepatocellular Carcinoma Treated with Apatinib

Ti Zhang, Huaqi Wang, M. Cao, 2021, Cancer management and research.

Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma

Xiaoying Gu, Ti Zhang, Qiang Li, 2020, Cancer management and research.

Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial

Wei Zhang, Ti Zhang, Qiang Li, 2020, Annals of Translational Medicine.

Resection of “down-staged” advanced hepatocellular carcinoma after treatment with the VEGFR2 inhibitor apatinib: five cases report

Ti Zhang, Qiang Li, T. Song, 2020, Translational cancer research.

CMAR_A_240394 3163..3173

Xiaoying Gu, Ti Zhang, Qiang Li, 2020 .

Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma

Xiaoying Gu, M. Cao, Zhenyu Hou, 2022, BMC Gastroenterology.